About this trial
Malnutrition is common at the time of diagnosis of esogastric cancers. However, there are no recommendations regarding preoperative nutritional support (type and duration) or on the impact of refeeding on postoperative morbidity and mortality.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient undergoing surgery for esophageal cancer
Malnourished patient at the time of management
Receiving neoadjuvant treatment
Disqualifiers
Patient not malnourished at the time of management
Patient who did not receive neoadjuvant treatment
Trial population
Retrospective case-control study including patients with esophageal cancer treated with neoadjuvant therapy. The control group consists of patients who did not receive enteral or parenteral nutrition during neoadjuvant treatment. The case group consists of patients who received enteral or parenteral nutrition during neoadjuvant treatment.
Trial design
Case-control
Retrospective
Treatments tested in this trial
Enteral or parenteral nutrition
Dietary supplementPatients who did not receive enteral or parenteral nutrition during neoadjuvant treatment.
Treatment groups
Trial outcomes
Primary outcomes
Rate of postoperative complications according to the Clavien classification
Proportion of patients experiencing at least one postoperative complication, classified according to Clavien-Dindo, in malnourished patients with versus without nutritional support.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University Hospital, Bordeaux
Lead sponsor
French Eso-Gastric Tumors Working Group
Collaborator